Kriti Nutrients

  • Market Cap: Micro Cap
  • Industry: Edible Oil
  • ISIN: INE798K01010
  • NSEID: KRITINUT
  • BSEID: 533210
INR
73.81
-0.84 (-1.13%)
BSENSE

Feb 11

BSE+NSE Vol: 8.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.72 k (17.17%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

66.68%

Who are the top shareholders of the Kriti Nutrients?

06-Jun-2025

The top shareholders of Kriti Nutrients include Sakam Trading Private Limited with 61.72%, Chartered Finance & Leasing Limited at 4.41%, and individual investors holding 20%. Foreign institutional investors have a minor stake of 0.03%, and there are no pledged promoter holdings.

The top shareholders of Kriti Nutrients include the promoters, who hold a significant majority of the shares. The promoter with the highest holding is Sakam Trading Private Limited, which owns 61.72% of the company. Additionally, Chartered Finance & Leasing Limited is the highest public shareholder, holding 4.41%. Individual investors collectively hold 20.0% of the shares, while foreign institutional investors (FIIs) hold a minor stake of 0.03% through four different FIIs. Notably, there are no pledged promoter holdings.

View full answer

Who are in the management team of Kriti Nutrients?

06-Jun-2025

As of March 2023, the management team of Kriti Nutrients includes Shiv Singh Mehta (Chairman & Managing Director), Purnima Mehta (Non Executive Director), Saurabh Singh Mehta (Whole-time Director), and independent directors Rakesh Kalra, Manoj Fadnis, and C Bhaskar. They are responsible for the company's governance and strategic direction.

As of March 2023, the management team of Kriti Nutrients includes:<BR><BR>1. Shiv Singh Mehta - Chairman & Managing Director<BR>2. Purnima Mehta - Non Executive Director<BR>3. Saurabh Singh Mehta - Whole-time Director<BR>4. Rakesh Kalra - Independent Director<BR>5. Manoj Fadnis - Independent Director<BR>6. C Bhaskar - Independent Director<BR><BR>These individuals play key roles in the governance and strategic direction of the company.

View full answer

Has Kriti Nutrients declared dividend?

06-Jun-2025

Yes, Kriti Nutrients Ltd has declared a 30% dividend, amounting to 0.3 per share, with an ex-date of June 11, 2024. The dividend yield is 0.27%, and total returns have shown significant growth over the long term despite short-term fluctuations.

Kriti Nutrients Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 0.3<BR>- Ex-date: 11 Jun 24<BR><BR>Dividend Yield: 0.27%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -18.89%, with no dividend return, resulting in a total return of -18.89%.<BR><BR>Over the past year, the price return was 10.38%, with no dividend return, leading to a total return of 10.38%.<BR><BR>In the 2-year period, the price return was 148.91%, with a dividend return of 0.90%, culminating in a total return of 149.81%.<BR><BR>For the 3-year period, the price return was 123.92%, with a dividend return of 1.65%, resulting in a total return of 125.57%.<BR><BR>In the last 4 years, the price return was 165.15%, with a dividend return of 2.08%, leading to a total return of 167.23%.<BR><BR>Over the past 5 years, the price return was 371.99%, with a dividend return of 4.09%, resulting in a total return of 376.08%.<BR><BR>Overall, Kriti Nutrients has declared a dividend, which contributes to a modest dividend yield. The total returns over various periods indicate significant growth, especially over the long term, despite some fluctuations in the short term.

View full answer

Who are the peers of the Kriti Nutrients?

03-Jun-2025

Kriti Nutrients' peers include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, and others. In terms of management risk, growth, and capital structure, Kriti Nutrients shows average performance, with a 1-year return of 8.52%.

Peers: The peers of Kriti Nutrients are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, Gokul Refoils, Evexia Lifecare, Shri Venkatesh, Ajanta Soya, and Vijay Solvex.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods, Gokul Agro, Sundrop Brands, Kriti Nutrients, Gokul Refoils, Evexia Lifecare, Shri Venkatesh, Ajanta Soya, and Vijay Solvex. Below Average management risk is noted at AWL Agri Busine. Growth is Excellent at Patanjali Foods and Gokul Agro, while Good growth is seen at AWL Agri Busine. and the rest. Below Average growth is observed at Marico, Kriti Nutrients, Gokul Refoils, Evexia Lifecare, Shri Venkatesh, and Ajanta Soya. Excellent capital structure is noted at Marico, Kriti Nutrients, and Ajanta Soya, while Good capital structure is found at Patanjali Foods, AWL Agri Busine., Gokul Agro, and Sundrop Brands. Below Average capital structure is observed at Gokul Refoils, Evexia Lifecare, Shri Venkatesh, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Gokul Agro at 71.95%, while the lowest is AWL Agri Busine. at -27.15%. Kriti Nutrients has a 1-year return of 8.52%, which is higher than AWL Agri Busine. but lower than Gokul Agro. Additionally, Gokul Refoils, Evexia Lifecare, and Shri Venkatesh have negative six-month returns.

View full answer

What does Kriti Nutrients do?

17-Jul-2025

Kriti Nutrients Ltd specializes in Soya Seed Extraction and produces cooking oil under the "KRITI" brand. As of March 2025, it reported net sales of 2,000 Cr and a net profit of 49 Cr, with a market cap of INR 554 Cr.

Overview:<BR>Kriti Nutrients Ltd is engaged in the business of Soya Seed Extraction and the manufacturing and selling of cooking oil under its own brand "KRITI," operating within the Edible Oil industry and classified as a Micro Cap company.<BR><BR>History:<BR>Kriti Nutrients Ltd was incorporated in 1996. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Net Sales: 2,000 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 49 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 554 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 15.00 <BR>Industry P/E: 23 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.15 <BR>Return on Equity: 18.63% <BR>Price to Book: 2.75 <BR><BR>Contact Details:<BR>Address: Mehta Chambers, 34 Siyaganj Indore Madhya Pradesh : 452007 <BR>Tel: 91-731-2712100/2712133 <BR>Email: cs@kritiindia.com <BR>Website: http://www.kritiindia.com

View full answer

How big is Kriti Nutrients?

24-Jul-2025

As of 24th July, Kriti Nutrients Ltd has a market capitalization of 552.00 Cr, with recent net sales of 545.24 Cr and a net profit of 21.92 Cr. Shareholder's funds are 176.49 Cr, and total assets amount to 209.01 Cr.

As of 24th July, Kriti Nutrients Ltd has a market capitalization of 552.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Kriti Nutrients reported Net Sales of 545.24 Cr and a Net Profit of 21.92 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 176.49 Cr and Total Assets of 209.01 Cr.

View full answer

Is Kriti Nutrients technically bullish or bearish?

05-Aug-2025

As of August 4, 2025, Kriti Nutrients is in a bearish trend, supported by bearish signals from the MACD, RSI, and moving averages, despite a bullish KST on a weekly basis.

As of 4 August 2025, the technical trend for Kriti Nutrients has changed from mildly bearish to bearish. The current stance is bearish, with a moderate strength indicated by the weekly MACD and RSI both showing bearish signals. The daily moving averages also confirm a bearish outlook. While the KST on a weekly basis is bullish, it is offset by the overall bearish sentiment from other indicators such as the Bollinger Bands and OBV, which are both mildly bearish on a monthly basis. The lack of a clear trend in Dow Theory further supports the bearish stance.

View full answer

When is the next results date for Kriti Nutrients?

06-Aug-2025

Kriti Nutrients will announce its results on 12 August 2025.

Kriti Nutrients will declare its results on 12 August 2025.

View full answer

Is Kriti Nutrients overvalued or undervalued?

14-Nov-2025

As of November 13, 2025, Kriti Nutrients is considered very attractive and undervalued with a PE ratio of 14.26, an EV to EBITDA of 10.83, and a dividend yield of 3.63%, especially when compared to peers like Gokul Agro and Guj. Ambuja Exp, despite a challenging year-to-date return of -28.06% and a strong long-term performance of 180.43% over five years.

As of 13 November 2025, the valuation grade for Kriti Nutrients has moved from attractive to very attractive. The company is currently considered undervalued. Key ratios include a PE ratio of 14.26, an EV to EBITDA of 10.83, and a dividend yield of 3.63%. <BR><BR>In comparison with peers, Kriti Nutrients stands out against Gokul Agro, which is deemed very expensive with a PE ratio of 20.13, and Guj. Ambuja Exp, rated attractive with a PE of 23.43. Despite a challenging year-to-date return of -28.06%, Kriti Nutrients has shown strong long-term performance, with a 5-year return of 180.43%, indicating potential for recovery and growth.

View full answer

How has been the historical performance of Kriti Nutrients?

14-Nov-2025

Kriti Nutrients experienced declining profitability despite increased net sales, with operating profit and profit after tax both falling significantly in the fiscal year ending March 2025. Total assets rose, but cash flow from operations decreased, leading to a net cash outflow.

Answer:<BR>The historical performance of Kriti Nutrients shows a decline in profitability despite an increase in net sales.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Kriti Nutrients reported net sales of 734.34 Cr, up from 684.36 Cr in March 2024. However, total operating income remained the same as net sales, indicating no other operating income. The total expenditure increased to 686.31 Cr from 622.15 Cr, primarily driven by higher raw material costs, which rose to 599.90 Cr from 557.19 Cr. Operating profit (PBDIT) decreased to 55.79 Cr from 66.66 Cr, leading to a decline in operating profit margin from 9.09% to 6.54%. Profit before tax also fell to 49.78 Cr from 60.58 Cr, resulting in a profit after tax of 37.02 Cr, down from 45.29 Cr the previous year. The earnings per share decreased from 9.04 to 7.38, reflecting the overall decline in profitability. On the balance sheet, total assets increased to 237.80 Cr from 209.01 Cr, while total liabilities also rose, but total debt significantly decreased from 10.00 Cr to 1.20 Cr. Cash flow from operating activities dropped to 31.00 Cr from 49.00 Cr, contributing to a net cash outflow of 7.00 Cr compared to 9.00 Cr in the prior year.

View full answer

Are Kriti Nutrients Ltd latest results good or bad?

06-Feb-2026

Kriti Nutrients Ltd's latest results show strong sales growth with a net profit increase of 11.03% year-on-year, but declining operating margins and a 41.95% drop in stock price raise concerns about profitability and operational challenges. Overall, the results are more concerning than positive.

Kriti Nutrients Ltd's latest results present a mixed picture. On the positive side, the company reported a net profit of ₹9.16 crore for Q3 FY26, which is an 11.03% increase year-on-year. Additionally, net sales reached ₹224.31 crore, reflecting a strong year-on-year growth of 29.72%. This indicates that the company is successfully capturing market demand for its edible oil products.<BR><BR>However, there are significant concerns regarding profitability. The operating margin has decreased to 5.13%, down from 6.39% a year ago, indicating ongoing pressure on margins. The profit after tax margin also declined to 4.11% from 4.77% in the previous year. This trend of margin compression raises questions about the company's ability to sustain profitability amidst rising raw material costs and competitive pressures.<BR><BR>Moreover, the stock has faced considerable challenges, declining 41.95% over the past year, significantly underperforming the broader edible oil sector. The stock is currently trading 45.76% below its 52-week high, reflecting investor concerns about the company's operational challenges.<BR><BR>In summary, while Kriti Nutrients has shown strong sales growth, the declining margins and significant stock underperformance suggest that the overall results are more concerning than positive. Investors should closely monitor the company's ability to improve its margins in the upcoming quarters.

View full answer

Should I buy, sell or hold Kriti Nutrients Ltd?

06-Feb-2026

Why is Kriti Nutrients Ltd falling/rising?

10-Feb-2026

As of 10-Feb, Kriti Nutrients Ltd's stock price is rising to 74.65, with a 0.35% increase and strong performance over the past week and month, outperforming the Sensex. The stock's appeal is further enhanced by a high dividend yield of 4.46%, despite a slight decrease in delivery volume.

As of 10-Feb, Kriti Nutrients Ltd's stock price is rising, currently at 74.65, reflecting a change of 0.26 (0.35%) upward. The stock has shown positive performance over the past week, gaining 1.83%, which is significantly higher than the Sensex's increase of 0.64% during the same period. Additionally, over the last month, the stock has risen by 3.51%, again outperforming the Sensex, which rose by only 0.83%.<BR><BR>The stock has been on a consecutive gain streak for the last three days, with a total increase of 0.58% in that timeframe. Furthermore, the current price is supported by a high dividend yield of 4.46%, which can attract investors looking for income-generating investments. Despite a decrease in delivery volume by 10.33% compared to the five-day average, the stock remains liquid enough for trading, indicating ongoing interest.<BR><BR>Overall, the combination of recent positive returns, a high dividend yield, and outperformance against the benchmark indices contributes to the rising stock price of Kriti Nutrients Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 16.66%

 
2

Company has a low Debt to Equity ratio (avg) at 0.06 times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 7.66% and Operating profit at 13.15% over the last 5 years

 
4

Positive results in Dec 25

5

With ROE of 14.3, it has a Very Attractive valuation with a 1.6 Price to Book Value

6

Majority shareholders : Promoters

 
7

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Edible Oil

stock-summary
Market cap

INR 370 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

21

stock-summary
Dividend Yield

4.42%

stock-summary
Debt Equity

-0.20

stock-summary
Return on Equity

14.25%

stock-summary
Price to Book

1.64

Revenue and Profits:
Net Sales:
224 Cr
(Quarterly Results - Dec 2025)
Net Profit:
9 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (4.42%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.66%
0%
-15.66%
6 Months
-26.23%
2.98%
-23.25%
1 Year
-36.32%
3.10%
-33.22%
2 Years
-35.11%
3.09%
-32.02%
3 Years
52.03%
8.63%
60.66%
4 Years
48.51%
8.76%
57.27%
5 Years
65.68%
9.71%
75.39%

Latest dividend: 3 per share ex-dividend date: Nov-13-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Kriti Nutrients Declines 0.72% Despite Positive Q3: 3 Key Factors Shaping the Week

Key Events This Week

2 Feb: Downgrade to Sell on weak financials and bearish technicals

6 Feb: Positive financial trend reported with revenue growth and margin improvement

6 Feb: Q3 FY26 results highlight margin pressures despite revenue gains

6 Feb: Week closes at Rs.74.33 (-0.72%) vs Sensex +1.51%

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Feb-2026 | Source : BSE

Press Release of Unaudited Standalone & Consolidated Financial Results for the Quarter and Nine Months ended 31st December2025.

Regulation 33 Of SEBI (LODR) Regulations 2015- Submission Of Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended 31St December 2025.

05-Feb-2026 | Source : BSE

Submission of Unaudited Standalone & Consolidated Financial Results along with Limited Review Report for the Quarter and Nine Months ended 31st December2025.

Board Meeting Outcome for Outcome Of The 04/2025-26 Meeting Of Board Of Directors Held On Thursday 5Th February 2026 At The Corporate Office Of The Company As Per Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

05-Feb-2026 | Source : BSE

Outcome of the 04/2025-26 Meeting of Board of Directors held on Thursday 5th February 2026 at the Corporate Office of the Company as per Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kriti Nutrients Ltd has declared 300% dividend, ex-date: 13 Nov 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.66%
EBIT Growth (5y)
13.15%
EBIT to Interest (avg)
25.35
Debt to EBITDA (avg)
0.44
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
4.69
Tax Ratio
22.88%
Dividend Payout Ratio
3.32%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
22.71%
ROE (avg)
16.66%

Valuation key factors

Factor
Value
P/E Ratio
11
Industry P/E
21
Price to Book Value
1.64
EV to EBIT
9.50
EV to EBITDA
8.15
EV to Capital Employed
1.80
EV to Sales
0.38
PEG Ratio
NA
Dividend Yield
4.42%
ROCE (Latest)
18.68%
ROE (Latest)
14.25%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Sakam Trading Private Limited (61.72%)

Highest Public shareholder

Chartered Finance & Leasing Limited (5.05%)

Individual Investors Holdings

19.22%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 5.34% vs -7.03% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -0.22% vs 0.22% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "224.31",
          "val2": "212.93",
          "chgp": "5.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.51",
          "val2": "11.24",
          "chgp": "2.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.12",
          "val2": "0.12",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.21",
          "val2": "9.23",
          "chgp": "-0.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.13%",
          "val2": "5.28%",
          "chgp": "-0.15%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 22.31% vs 4.65% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -22.62% vs 6.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "441.98",
          "val2": "361.36",
          "chgp": "22.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.61",
          "val2": "30.88",
          "chgp": "-26.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.24",
          "val2": "0.24",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "18.44",
          "val2": "23.83",
          "chgp": "-22.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.12%",
          "val2": "8.55%",
          "chgp": "-3.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 24.71% vs 4.33% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -13.81% vs -12.18% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "666.29",
          "val2": "534.28",
          "chgp": "24.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.12",
          "val2": "41.93",
          "chgp": "-18.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.39",
          "chgp": "-7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "27.65",
          "val2": "32.08",
          "chgp": "-13.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.12%",
          "val2": "7.85%",
          "chgp": "-2.73%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 7.30% vs -14.12% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -18.26% vs 117.74% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "734.34",
          "val2": "684.36",
          "chgp": "7.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "48.03",
          "val2": "62.21",
          "chgp": "-22.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.57",
          "val2": "1.39",
          "chgp": "-58.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "37.02",
          "val2": "45.29",
          "chgp": "-18.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.54%",
          "val2": "9.09%",
          "chgp": "-2.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
224.31
212.93
5.34%
Operating Profit (PBDIT) excl Other Income
11.51
11.24
2.40%
Interest
0.12
0.12
Exceptional Items
0.00
0.00
Standalone Net Profit
9.21
9.23
-0.22%
Operating Profit Margin (Excl OI)
5.13%
5.28%
-0.15%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 5.34% vs -7.03% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -0.22% vs 0.22% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
441.98
361.36
22.31%
Operating Profit (PBDIT) excl Other Income
22.61
30.88
-26.78%
Interest
0.24
0.24
Exceptional Items
0.00
0.00
Standalone Net Profit
18.44
23.83
-22.62%
Operating Profit Margin (Excl OI)
5.12%
8.55%
-3.43%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 22.31% vs 4.65% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -22.62% vs 6.67% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
666.29
534.28
24.71%
Operating Profit (PBDIT) excl Other Income
34.12
41.93
-18.63%
Interest
0.36
0.39
-7.69%
Exceptional Items
0.00
0.00
Standalone Net Profit
27.65
32.08
-13.81%
Operating Profit Margin (Excl OI)
5.12%
7.85%
-2.73%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 24.71% vs 4.33% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -13.81% vs -12.18% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
734.34
684.36
7.30%
Operating Profit (PBDIT) excl Other Income
48.03
62.21
-22.79%
Interest
0.57
1.39
-58.99%
Exceptional Items
0.00
0.00
Standalone Net Profit
37.02
45.29
-18.26%
Operating Profit Margin (Excl OI)
6.54%
9.09%
-2.55%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 7.30% vs -14.12% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -18.26% vs 117.74% in Mar 2024

stock-summaryCompany CV
About Kriti Nutrients Ltd stock-summary
stock-summary
Kriti Nutrients Ltd
Micro Cap
Edible Oil
Kriti Nutrients Ltd was incorporated in the year 1996. The Company is in the business of Soya Seed Extraction and Manufacturing & Selling of cooking oil under its own brand "KRITI". The unit has a state of the art manufacturing setup which includes solvent extraction plants, vegetable oil refinery, lecithin plant, effluent treatment plant, fluidized bed boilers and an in-house tin and jar manufacturing facility.
Company Coordinates stock-summary
Company Details
Mehta Chambers, 34 Siyaganj Indore Madhya Pradesh : 452007
stock-summary
Tel: 91-731-2712100/2712133
stock-summary
cs@kritiindia.com
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore